Double Outlet Right Ventricle (DORV) — Clinical Classification #6: Remote (Noncommitted) VSD
A remote VSD (often termed a noncommitted VSD) is the DORV subtype in which the VSD is not aligned with either arterial valve—it is separated from both outflow tracts by a substantial muscular segment. In DORV, the VSD is the obligate LV exit, so when that exit is remote, LV egress becomes a geometry problem: the surgeon must decide whether a safe, durable LV-to-great-artery pathway can be constructed without creating obstruction or compromising valve function [1,2].
1) Why remote VSD DORV is a “decision lesion”
Remote VSD DORV is less about a single operative “standard” and more about choosing the right physiologic destination:
- Complex biventricular repair is often feasible, but requires precise anatomic compatibility for intracardiac routing [2,3].
- If that compatibility is absent (especially due to AV valve chordal constraints or unfavorable tunnel geometry), a single-ventricle pathway is not a fallback—it is the more reliable long-term strategy [2,11].
This is why remote VSD DORV behaves like a crossroads lesion: small differences in 3D relationships can flip the best pathway.
2) Typical physiology and early presentation
When pulmonary blood flow is unobstructed, many patients present with pulmonary overcirculation:
- Large, nonrestrictive VSD + low PVR → Qp ≫ Qs → tachypnea, feeding difficulty, failure to thrive, recurrent respiratory infections, and early heart failure physiology.
Early physiologic control
- Pulmonary artery banding remains a classic and effective bridge to:
- protect the pulmonary vascular bed,
- stabilize symptoms and growth, and
- “buy time” for definitive pathway selection once anatomy is fully defined and the patient is larger [2,11].
3) The core surgical question: Can we create a good LV exit?
A “successful” biventricular plan is not defined by whether a tunnel can be built—it is defined by whether the tunnel will remain non-obstructive, valve-sparing, and growth-tolerant.
A. VSD–outflow geometry (the tunnel must be wide, short, and smooth)
Key checks:
- Distance from VSD to target outflow (usually aorta) and the directional alignment in 3D [1,2].
- Need for VSD enlargement and/or conal/muscle resection to prevent a long, angulated, restrictive pathway [3,6].
- Likelihood of creating LVOT obstruction (LVOTO) immediately or with growth (the dominant late hazard in many series) [3,7].
B. AV valve chordal anatomy (often the true deal-breaker)
- Straddling/overriding AV valve tissue or chordae crossing the intended tunnel route can force:
- a narrowed or displaced baffle,
- residual shunting,
- or unacceptable AV valve regurgitation risk [2,6,7].
C. Ventricular balance and atrioventricular valve adequacy
- Balanced ventricles, adequate AV valve size/competence, and a repair that preserves two non-obstructed inflow–outflow relationships are prerequisites for a durable biventricular outcome [2,7].
4) If pursuing biventricular repair: what the operation must accomplish
Goal 1: A durable, non-obstructive LV outflow
Typical components:
- Intraventricular baffle/tunnel from VSD to the systemic outflow [2,3].
- VSD enlargement (frequently required) to avoid a restrictive baffle or high-velocity LVOT [3,6].
- Muscle bundle/conal resection to “straighten” and enlarge the pathway [3,6].
Practical surgical principle:
- The tunnel should behave like a physiologic LVOT—not merely a channel that “works on the table.”
Goal 2: A durable, non-obstructive RV outflow
Depending on the chosen routing strategy, RVOT management must be planned as deliberately as the LV pathway—because an excellent LV tunnel is not a victory if the remaining outflow becomes the next bottleneck [2,7,11].
5) Strategy spectrum: how contemporary repairs are selected
Remote VSD repair has evolved into a strategy toolkit, selected by anatomy rather than by label.
A. “Classic” intraventricular rerouting (often to the aorta)
- Widely used, effective, but most vulnerable to:
- subaortic/LVOT obstruction, and
- late reinterventions for tunnel-related issues [3,7].
B. Techniques that improve tunnel geometry
- Multiple-patch concepts can simplify complex intracardiac routing and reduce geometric compromise in selected anatomies [4].
C. Alternative assignment of the VSD (rerouting to PA) + arterial switch (selected cases)
- When geometry favors VSD-to-PA routing, VSD rerouting to the pulmonary artery with arterial switch is a recognized biventricular solution in appropriately selected patients [5].
D. “Intraventricular conduit” approach (newer concept; typically older/larger patients)
- A dedicated intraventricular conduit technique has been reported as an option, particularly in patients >2 years, acknowledging practical size constraints and the need for careful timing/patient selection [8,9].
6) Outcomes: the message from the literature
Across multiple series, the headline is optimistic but nuanced: biventricular repair is often feasible, yet reoperation risk—especially for LVOT/subaortic obstruction—remains a defining long-term issue.
- In a classic surgical series of biventricular repair for noncommitted VSD DORV, hospital mortality was 9% (2/23) and reoperation occurred in 35%, most commonly for subaortic stenosis—a clear signal that the subaortic region remains the long-term “price of the tunnel” in many anatomies [3].
- In a larger single-center experience emphasizing strategic rerouting and adjunctive procedures (including tricuspid procedures and VSD enlargement to optimize geometry), estimated overall survival was 87.1% at 5 years, and late tunnel obstruction risk differed substantially depending on the chosen routing strategy [6].
- Multicenter analyses confirm that both anatomic characteristics and the initial biventricular strategy influence mortality and reoperation—supporting a modern “anatomy-first, strategy-tailored” approach rather than a one-technique mindset [7].
- Broader DORV outcome frameworks and nomenclature-based results reinforce that classification is useful only when it informs geometry, feasibility, and risk [1,10].
Bottom line: remote VSD DORV is “repairable” in many patients, but durability is won or lost in the details of tunnel geometry, AV valve preservation, and long-term LVOT protection [2,3,6,7].
7) Imaging and surgical planning checklist (high-yield)
When reviewing echo/CT/MRI, answer these in order:
- Define the VSD in 3D
- LV-side location and RV-side opening; relation to septal structures and conal anatomy [1,2].
- Identify the most “forgiving” outflow assignment
- Which great artery provides the shortest, straightest, widest LV egress route? [2,6]
- Map AV valve chordae relative to the intended tunnel
- Any straddling/overriding tissue or chordal crossings that will distort the baffle or valve? [2,6,7]
- Predict obstruction before it happens
- Where will the tunnel narrow (inlet, mid-tunnel, subaortic region)? What will growth do to that geometry? [3,6,7]
- Decide whether physiology needs staging now
- If Qp is excessive, PA banding as bridge; if flow is inadequate, plan controlled augmentation—always aligned with the intended final pathway [2,11].
Key message
Remote (noncommitted) VSD DORV is a geometry-driven crossroads lesion. Many infants begin with physiology dominated by pulmonary overcirculation, often stabilized by PA banding, but definitive management depends on whether a safe, durable LV egress pathway can be created without LVOTO, residual shunting, or AV valve compromise. When that geometry is unfavorable—particularly due to AV valve chordae or excessive tunnel complexity—single-ventricle palliation may be the more reliable long-term plan [2,7,11].
References
[1] Kleinert S, Sano T, Weintraub RG, Mee RB, Karl TR, Wilkinson JL. Anatomic features and surgical strategies in double-outlet right ventricle. Circulation. 1997;96(4):1233-1239.
[2] Lacour-Gayet F. Biventricular repair of double outlet right ventricle with noncommitted ventricular septal defect. Semin Thorac Cardiovasc Surg Pediatr Card Surg Annu. 2002;5:163-172.
[3] Belli E, Serraf A, Lacour-Gayet F, Hubler M, Zoghby J, Houyel L, Planche C. Double-outlet right ventricle with non-committed ventricular septal defect. Eur J Cardiothorac Surg. 1999;15(6):747-752.
[4] Barbero-Marcial M, Tanamati C, Atik E, Ebaid M. Intraventricular repair of double-outlet right ventricle with noncommitted ventricular septal defect: advantages of multiple patches. J Thorac Cardiovasc Surg. 1999;118(6):1056-1067.
[5] Lacour-Gayet F, Haun C, Ntalakoura K, Belli E, Houyel L, Marcsek P, Wagner F, Weil J. Biventricular repair of double outlet right ventricle with non-committed ventricular septal defect (VSD) by VSD rerouting to the pulmonary artery and arterial switch. Eur J Cardiothorac Surg. 2002;21(6):1042-1048.
[6] Li S, Ma K, Hu S, Hua Z, Yan J, Pang K, Wang X, Yan F, Liu J, Zhang S, Chen Q. Biventricular repair for double outlet right ventricle with non-committed ventricular septal defect. Eur J Cardiothorac Surg. 2015;48(4):580-587.
[7] Villemain O, Belli E, Ladouceur M, Houyel L, Jalal Z, Lambert V, Ly M, Vouhé P, Bonnet D. Impact of anatomic characteristics and initial biventricular surgical strategy on outcomes in various forms of double-outlet right ventricle. J Thorac Cardiovasc Surg. 2016;152(3):698-706.e3.
[8] Lu T, Li J, Hu J, Huang C, Tan L, Wu Q, Wu Z. Biventricular repair of double-outlet right ventricle with noncommitted ventricular septal defect using intraventricular conduit. J Thorac Cardiovasc Surg. 2020;159(6):2397-2403.
[9] Jaggers J, Stone M. Commentary: Intraventricular conduit repair for double-outlet right ventricle with noncommitted ventricular septal defect-How bright is the light at the end of the tunnel? J Thorac Cardiovasc Surg. 2020;159(6):2404-2405.
[10] Artrip JH, Sauer H, Campbell DN, Mitchell MB, Haun C, Almodovar MC, Hraska V, Lacour-Gayet F. Biventricular repair in double outlet right ventricle: surgical results based on the STS-EACTS International Nomenclature classification. Eur J Cardiothorac Surg. 2006;29(4):545-550.
[11] Cetta F, Boston US, Dearani JA, Hagler DJ. Double outlet right ventricle: opinions regarding management. Curr Treat Options Cardiovasc Med. 2005;7(5):385-390.